Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.48 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.43 |
| ▸ | ABAT | P80404 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | APAF1 | O14727 | 1/20 | 0.37 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL15643622 | 0.89 | CDC25A (0.44) | CA2CA12CA1CA7CA13 | |
| SCHEMBL8637757 | 0.82 | CA2 (0.61) | CA2CA12CA1CA7CA13 | |
| SCHEMBL1025762 | 0.79 | CA2 (0.47) | CA2CA12CA1CA7CA13 | |
| SCHEMBL2916575 | 0.79 | ALDH1A1 (0.48) | ALDH1A1ALDH5A1ABATHPGDMAPT | |
| SCHEMBL8595279 | 0.79 | ALDH1A1 (0.54) | CA2CA12CA1CA7CA13 | |
| SCHEMBL11170850 | 0.79 | ALDH1A1 (0.50) | ALDH1A1ALDH5A1ABATHPGDMAPT | |
| SCHEMBL1246027 | 0.77 | UNG (0.42) | CA2CA12CA1CA7CA13 | |
| SCHEMBL3405047 | 0.76 | ALDH1A1 (0.50) | CA2CA12CA1CA7CA13 | |
| SCHEMBL3900894 | 0.75 | CA2 (0.55) | CA2CA12CA1CA7CA13 | |
| SCHEMBL8529367 | 0.75 | CA2 (0.55) | CA2CA12CA1CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132298-A1 | A METHOD FOR PRODUCING INTERFERENCE ELEMENTS | BASF SE (DE) | 2026-05-14 | — | — | US | disclosed |
| EP-4709544-A1 | COMPOSITIONS, COMPRISING SILVER NANOPLATELETS | BASF SE (DE) | 2026-03-18 | — | — | EP | disclosed |
| US-12515253-B2 | Compositions, comprising silver nanoplatelets | BASF SE (DE) | 2026-01-06 | — | — | US | disclosed |
| US-20250263566-A1 | CASTING LACQUER FOR SCREEN PRINTING | DE LA RUE INTERNATIONAL LIMITED (GB) | 2025-08-21 | — | — | US | disclosed |
| US-12325806-B2 | Photocurable composition for use in 3D printing | BASF SE (DE) | 2025-06-10 | — | — | US | disclosed |
| US-12296391-B2 | Security element | BASF SE (DE) | 2025-05-13 | — | — | US | disclosed |
| EP-4337734-B1 | COMPOSITIONS, COMPRISING PLATELET-SHAPED TRANSITION METAL PARTICLES | BASF SE (DE) | 2025-04-23 | — | — | EP | disclosed |
| US-12208447-B2 | Compositions, comprising silver nanoplatelets | BASF SE (DE) | 2025-01-28 | — | — | US | disclosed |
| EP-4490577-A1 | CASTING LACQUER FOR SCREEN PRINTING | BASF SE (DE) | 2025-01-15 | — | — | EP | disclosed |
| WO-2024231418-A1 | COMPOSITIONS, COMPRISING SILVER NANOPLATELETS | BASF SE (DE) | 2024-11-14 | — | — | WO | disclosed |
| WO-2005064008-A1 | METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2005-07-14 | — | — | WO | disclosed |
| EP-1509537-A2 | CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH | GILEAD SCIENCES, INC. (US) | 2005-03-02 | — | — | EP | disclosed |
| WO-2003090690-A2 | CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH | GILEAD SCIENCES, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| EP-0570780-B1 | Chloroethylsulphonylbenzaldehydes | BASF AG (DE) | 1996-03-06 | — | — | EP | disclosed |
| US-5493057-A | INTERMEDIATES FOR REACTIVE DYES | BASF AKTIENGESELLSCHAFT (DE) | 1996-02-20 | — | — | US | disclosed |
| EP-0570780-A1 | Chloroethylsulphonylbenzaldehydes | BASF Aktiengesellschaft (DE) | 1993-11-24 | — | — | EP | disclosed |
| EP-0309839-B1 | PROCESS FOR THE PREPARATION OF OXYETHYL MERCAPTOBENZALDEHYDES, AND THEIR OXIDATION PRODUCTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-03-04 | — | — | EP | disclosed |
| US-4922014-A | Process for the preparation of oxethylmercaptobenzaldehydes and their oxidation products | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-05-01 | — | — | US | disclosed |
| EP-0309839-A1 | Process for the preparation of oxyethyl mercaptobenzaldehydes, and their oxidation products | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-04-05 | — | — | EP | disclosed |
| EP-0089154-A2 | Ethanolamine derivatives, their preparation and use in pharmaceutical compositions | BEECHAM GROUP PLC (GB) | 1983-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132298-A1 | A METHOD FOR PRODUCING INTERFERENCE ELEMENTS | COPE, COPB2, C9 | CA2 1824/4885CA12 214/4885CA1 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.